Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1874 studies found for:    "Liver Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)
Condition: Liver Cancer
Interventions: Procedure: Electrochemotherapy;   Device: Cliniporator Vitae®;   Drug: Bleomycin PHC 15 e. (United States Pharmacopeia - USP)
22 Completed Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
Condition: Liver Cancer
Intervention: Drug: arsenic trioxide
23 Completed Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients
Condition: Hepatocellular Cancer
Intervention: Drug: Sorafenib
24 Unknown  Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Intervention: Drug: antineoplaston A10
25 Completed Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed
Condition: Liver Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: thalidomide
26 Terminated
Has Results
Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer
Condition: Hepatocellular Cancer
Intervention: Drug: Tivozanib
27 Not yet recruiting Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer
Condition: Hepatocellular Cancer
Interventions: Drug: Sorafenib (SOR);   Drug: Hydroxychloroquine (HCQ)
28 Terminated
Has Results
Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Condition: Liver Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: sunitinib malate;   Other: laboratory biomarker analysis;   Procedure: hepatic artery embolization;   Procedure: quality-of-life assessment
29 Unknown  Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Condition: Liver Cancer
Interventions: Drug: doxorubicin-eluting beads;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Other: pharmacological study;   Procedure: quality-of-life assessment
30 Unknown  Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
Condition: Liver Tumors
Intervention: Radiation: Stereotactic Body Radiation Therapy
31 Completed Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors
Condition: Malignant Liver Tumors
Interventions: Procedure: irreversible electroporation;   Device: nanoknife AngioDynamics US Ltd
32 Completed Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors
Conditions: Liver Cancer;   Hepatic Tumors
Intervention: Device: PET/CT Scan
33 Unknown  Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Condition: Hepatocellular Cancer
Intervention: Drug: [Met5]-enkephalin (Infusion of opioid growth factor )
34 Terminated Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
Condition: Liver Tumors
Intervention: Drug: Definity®
35 Recruiting Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Interventions: Drug: Trametinib;   Drug: Sorafenib
36 Recruiting A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms
Condition: Liver Neoplasms
Interventions: Other: CEUS guided biopsy;   Other: US guided biopsy;   Device: Ultrasound
37 Recruiting Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE
Condition: Advanced Adult Primary Liver Cancer
Intervention: Drug: Oxaliplatin and fluorouracil
38 Recruiting Study of PD-1 Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer
Condition: Advanced Liver Cancer
Interventions: Biological: Activated CIK and bispecific antibody;   Biological: Activated CIK
39 Active, not recruiting Chinese Liver Cancer Clinical Survey
Condition: Primary Liver Cancer
Intervention:
40 Terminated
Has Results
Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)
Condition: Liver Cancer
Intervention: Drug: Sunitinib Malate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.